arrow_back Back to App

Increased Research and Support for Liver Illnesses and Liver Cancer

This act boosts funding and coordination for research into liver cancer and other liver diseases, including hepatitis B and C. Citizens can expect improved prevention programs, early detection, and treatment, especially for high-risk groups. The changes aim to enhance public health by better understanding and combating these diseases.
Key points
Increased funding for research on liver cancer and other liver diseases, including early detection and new treatments.
Development of prevention programs, screenings, and vaccinations, especially for high-risk groups such as Asian American, Pacific Islander, Hispanic/Latino, and African immigrant communities.
Establishment of a national data system and information clearinghouse for liver diseases, facilitating access to knowledge for patients and healthcare professionals.
Renaming of a research institute to the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases, emphasizing a greater focus on liver diseases.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_3041
Sponsor: Sen. Duckworth, Tammy [D-IL]
Process start date: 2021-10-21
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Liver Illness Visibility, Education, and Research Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_3041.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-10-21.

What are the main provisions?

Key points include:

  • Increased funding for research on liver cancer and other liver diseases, including early detection and new treatments.
  • Development of prevention programs, screenings, and vaccinations, especially for high-risk groups such as Asian American, Pacific Islander, Hispanic/Latino, and African immigrant communities.
  • Establishment of a national data system and information clearinghouse for liver diseases, facilitating access to knowledge for patients and healthcare professionals.
  • Renaming of a research institute to the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases, emphasizing a greater focus on liver diseases.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Duckworth, Tammy [D-IL].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health